An Amniotic Membrane Injection Comparing Two Doses (1 mL and 2mL Injection) in the Treatment of Osteoarthritis of the Knee
Status:
Withdrawn
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the dose effect of a single injectable acellular
amniotic membrane derived allograft injection for the treatment of knee osteoarthritis and to
confirm whether the use of 2 mL of the same amniotic injection offers a statistically
significant advantage over the 1 mL injection.
Phase:
Phase 4
Details
Lead Sponsor:
Illinois Center for Orthopaedic Research and Education